EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 13, 2019
Media advisory: To contact corresponding author R. Nick Bryan, M.D., Ph.D., email Shahreen Abedin at Shahreen.Abedin@austin.utexas.edu. The full study, editorial, related article and video are linked to this news release. The summary video can be viewed on this page and embedded on your website by copying and pasting the HTML code below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time: https://jamanetwork.com/journals/jama/fullarticle/2747671?guestAccessKey=55000849-d77a-41e2-b684-57f9abd130ed&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081319
Bottom Line: Intensive blood pressure control among adults with high blood pressure was associated with a smaller increase in brain white matter lesions (a marker of small vessel disease and a risk factor for dementia) compared to standard blood pressure control, although the difference was small. Hypertension is a risk factor for developing white matter lesions. This analysis is a substudy of a randomized clinical of 449 patients with high blood pressure who had initial brain magnetic resonance imaging (MRI) and a follow-up MRI after four years. Researchers report intensive systolic blood pressure control (goal of less than 120 mm Hg) was associated with a smaller increase in white matter lesion volume compared with standard treatment (goal of less than 140 mm Hg). There also was a greater decrease in total brain volume, although the difference was small and the significance of this finding is unclear. Limitations of the study include the relatively short duration of the intervention and follow-up. Given the limited size of this study, it’s also not possible to correlate changes in brain structure with dementia occurrence.
Authors: R. Nick Bryan, M.D., Ph.D., University of Texas at Austin, and coauthors
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations
Video embed code: